A 59-year old female participant presented with a broken hip due to a fall. She has cerebral palsy with developmental delay, depression, seizure disorder, and a history of falls and alcoholism. The PACE physician contacted the CK clinical pharmacist because within the six months since enrollment, her phenytoin dose had been changed twice and had been a challenge to manage.   

Click here for the CareKinesis Clinical Pharmacist intervention. 

On August 18, 2014, tramadol (Ultram) was placed into the Schedule IV of the Controlled Substances Act, in an effort to reduce abuse and diversion of this medication. For more tramadol information, click here.  

The DEA recently published a stricter narcotic rule that categorizes hydrocodone combination products (e.g., pain medications including Vicodin and Norco) as a Schedule II drug. This rule will take effect late September, 2014. For more hydrocodone information, click here.